Hills and Valleys is a podcast that uncovers stories from leaders in healthcare, tech, and everything in between. Straight from the heart of Silicon Valley, we give you a look at the good, the bad, and the future, one episode at a time. Brought to you by Potrero Medical. Listen to the podcast on any […]
Ep23: Dr. Wael Barsoum, President & Chief Transformation Officer at HOPCo Read More »
American Diabetes Association Unveils Amputation Prevention Alliance to Address the Diabetes-Related Amputation Pandemic Read more…
Hills and Valleys is a podcast that uncovers stories from leaders in healthcare, tech, and everything in between. Straight from the heart of Silicon Valley, we give you a look at the good, the bad, and the future, one episode at a time. Brought to you by Potrero Medical. Listen to the podcast on any
Ep22: Dr. Jayne Morgan, MD – Clinical Director, Covid Task Force at Piedmont Healthcare Read More »
New research examining patients with healed diabetic foot ulcers revealed that daily foot temperature monitoring can result in lower rates of hospitalization and foot ulcer recurrence in high-risk patients, according to a study in BMJ Open Diabetes Research & Care. The study used Podimetrics SmartMats to take the temperature of participants’ feet and to scan
Daily foot temperature monitoring leads to fewer hospitalizations, amputations and more Read More »
There have been serious questions about whether the recent boom in virtual care is just a blip. | The recent announcement that Teladcoc and Livongo are merging sends a powerful signal about where virtual care can go. Together, they can combine Teladoc’s large roster of providers who specialize in one-on-one virtual interactions with Livongo’s large-scale
Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced completion of enrollment in its U.S. IDE trial studying the use of LimiFlex with a decompression for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis. The trial compares outcomes of patients who receive either LimiFlex or transforaminal lumbar interbody fusion (TLIF) after
Next-generation technology enhances ease-of-use for physicians and streamlines manufacturability The Company is targeting limited market introduction in Q42020 and commercial launch of the Cerene® Device in the first half of 2021 Emeryville, California, July 21, 2020 – Channel Medsystems® (“Channel”), a company dedicated to bringing innovation to the delivery of women’s healthcare, today announced that
Potential to reduce ventilation duration and increase the availability of ventilators CRESTWOOD, KY, 4th May 2020 – Liberate Medical today announced that it has received Federal Drug Administration (FDA) Emergency Use Authorization for its VentFree™ Respiratory Muscle Stimulator, intended to be used to reduce disuse atrophy of the abdominal wall muscles, which may reduce the
Latest Guidelines to Enhance Patient Recovery after Cardiac Surgery Strongly Recommend: Maintenance of Chest Tube Patency to Prevent Complications OMAHA, Neb. – January 21, 2020 – Centese, Inc. today announced completion of the first clinical study of its Thoraguard® digital drainage system used in cardiac surgery at Stanford University Medical Center. Thoraguard is the first
First Thoraguard Study Completed at Stanford University Medical Center – Read More »
Emeryville, California, December 18, 2019 — Channel Medsystems®, a company dedicated to bringing innovation to the delivery of women’s healthcare, today announced that its Cerene® Cryotherapy Device has received one of Popular Science’s Best of What’s New Awards for 2019. The Cerene® Cryotherapy Device was recognized for offering a new, minimally invasive alternative for the